Ironwood Pharmaceuticals, Inc. Class A Share Price

Ironwood Pharmaceuticals, Inc. Class A Share Price

NASDAQ: IRWD | Small Cap
$3.49
-$0.13 (-3.46%) Last updated on 31 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Ironwood Pharmaceuticals, Inc. Class A Stock Performance

Open
$3.61
Prev. Close
$3.62
Circuit Range
N/A
Day Range
$3.46 - $3.64
Year Range
$1.48 - $5.76
Volume
1,14,962
Average Traded
$3.52

Ironwood Pharmaceuticals, Inc. Class A Share Price Today

As of 31 October 2026, Ironwood Pharmaceuticals, Inc. Class A's share price is $3.49. The stock opened at $3.61, compared to its previous close of $3.62. During today's trading session, Ironwood Pharmaceuticals, Inc. Class A's share price traded between $3.46 and $3.64, with an average price of $3.55. Over the past 52 weeks, the stock has recorded a high of $5.76 and a low of $1.48. In terms of performance, Ironwood Pharmaceuticals, Inc. Class A's share price has declined by 15.29% over the last six months and is up 82.72% on a year-on-year basis.

Ironwood Pharmaceuticals, Inc. Class A Share Price Chart

Line chart of the Ironwood Pharmaceuticals, Inc. Class A price trend over the selected period. The price fell overall, ranging from 3.46 to 3.64, ending at 3.49.
$3.46$3.64
L
Show Current Price
H

Ironwood Pharmaceuticals, Inc. Class A Stock Fundamentals & Key Indicators

Market Cap
$564.83M
PE Ratio (TTM)
4.61
Dividend Yield
0.00%
EPS (TTM)
$0.79
Revenue (TTM)
$296.15B
Return On Equity (TTM)
-80.24%
Profit Margin
8.11%
Debt to Equity
-2.38
Quarterly Earnings Growth YoY
27.97%

Ironwood Pharmaceuticals, Inc. Class A Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$122.06$47.71$106.51$113.04
Net Profit$40.08-$2.28$40.77$51.29
Net Profit Margin32.84%-4.78%38.28%45.37%
Income ChangeN/A-105.69%1888.16%25.80%

Ironwood Pharmaceuticals, Inc. Class A Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$410.60$442.74$351.41$296.15
Net Profit$175.07-$1002.24$0.88$24.02
Net Profit Margin42.64%-226.37%0.25%8.11%
Income ChangeN/A-672.48%100.09%2629.55%

About Ironwood Pharmaceuticals, Inc. Class A

Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.

Ironwood Pharmaceuticals, Inc. Class A Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$3.87
$3.49
-12.20%
Sep 2026
$4.23
$3.98
-6.25%
Aug 2026
$4.33
$4.24
+0.24%
Jul 2026
$4.18
$4.23
+0.24%
Jun 2026
$3.52
$4.22
+17.88%
May 2026
$4.13
$3.58
-13.11%
Apr 2026
$3.57
$4.12
+17.38%
Mar 2026
$3.27
$3.51
+3.08%
Feb 2026
$4.84
$3.40
-30.51%
Jan 2026
$4.59
$4.90
+45.83%
Dec 2025
$3.46
$3.36
-3.72%
Nov 2025
$1.97
$3.49
+82.72%

IRWD Share Price FAQs